TheProfitWatch

TERN - Terns Pharmaceuticals, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
26.09 0.16 (0.59%) -0.02 (-0.08%) -0.05 (-0.21%) 0.23 (0.88%) -0.09 (-0.34%) 0.26 (0.98%) -0.02 (-0.08%) -0.09 (-0.34%)

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.26
Diluted EPS:
-0.26
Basic P/E:
-100.9423
Diluted P/E:
-100.9423
RSI(14) 1m:
41.82
VWAP:
26.27
RVol:

Events

Period Kind Movement Occurred At

Related News